Search

Search Results

• High-Dose Chemotherapy for Grade 3B Relapsed Follicular Lymphoma with Deletions of Loci of BCL6 (3q27) and TP53 (17p13) Genes: Case Report and Literature Review

  E.E. Zvonkov, Nelli Georgievna Gabeeva, M.V. Firsova, E.V. Moiseeva, V.V. Troitskaya, L.A. Kuz’mina, T.N. Obukhova, A.M. Kovrigina, E.N. Parovichnikova, V.G. Savchenko

  36–43

  01.01.2015

• Rare Disease — Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma: Literature Review and Own Data

  E.A. Demina, G.S. Tumyan, A.A. Chekan, M.Yu. Kichigina, A.S. Antipova, N.A. Probatova, A.I. Pavlovskaya, N.V. Kokosadze, A.M. Kovrigina, O.P. Trofimova, E.A. Osmanov

  522-532

  01.10.2014

• Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes and Clinical Significance of WT1 Gene Overexpression

  N.N. Mamaev, A.V. Gorbunova, T.L. Gindina, E.V. Morozova, Ya.V. Gudozhnikova, O.A. Slesarchuk, V.N. Ovechkina, A.A. Rats, E.G. Boichenko, E.A. Ukrainchenko, V.M. Kravtsova, A.V. Evdokimov, I.M. Barkhatov, S.N. Bondarenko, B.V. Afanas’ev

  551-563

  01.10.2014

• Rationale for Maintenance Treatment of Patients with Acute Myeloid Leukemia below 65 Years of Age, According to Data of a Retrospective Analysis of Protocols AML-2000 and AML-2007

  S.V. Semochkin, T.N. Tolstykh, V.V. Lunin, N.K. Khuazheva, A.I. Kostin, S.A. Chernysh, M.E. Pochtar, V.L. Ivanova

  564-572

  01.10.2014

• Quality of Life of Patients with Lymphomas at Different Time-Points after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

  N.E. Mochkin, D.A. Fedorenko, V.Ya. Mel’nichenko, T.I. Ionova, T.P. Nikitina, K.A. Kurbatova, A.A. Novik

  577-582

  01.10.2014

• Imatinib Generics: Myths and Reality (Literature Review and Our Experience)

  K.M. Abdulkadyrov, V.A. Shuvaev, M.S. Fominykh

  311-316

  01.07.2014

• High-Dose Chemotherapy and Autologous Stem Cells Transplantation for Relapsed/Refractory Hodgkin’s Lymphoma. Is There an Equal Right to Life?

  N.V. Zhukov, A.G. Rumyantsev, A.L. Uss, N.F. Milanovich, V.V. Ptushkin, B.V. Afanasyev, N.B. Mikhaylova, V.B. Larionova, E.A. Demina, E.E. Karamanesht, N.G. Tyurina, M.A. Vernyuk, A.D. Kaprin

  317-326

  01.07.2014

• Role of Catalase in Protection of Cancer Cells from Oxidative Stress induced by Binary Catalytic System “Teraphtal + Ascorbic acid”

  Т.А. Sidorova, M.S. Vagida, O.L. Kaliya, G.K. Gerasimova

  282-289

  01.07.2014

• Role of Bendamustine in Treatment of Multiple Myeloma

  O.M. Votyakova

  301-310

  01.07.2014

• Efficacy of platelet transfusions during standard induction chemotherapy in patients with acute myeloid leukemia

  B. Davaasambuu, S.V. Gritsayev, T.V. Glazanova, S.A. Tiranova, N.A. Potikhonova, I.S. Martynkevtch, A.V. Chechetkin

  213-219

  01.04.2014

• Management of relapsed and refractory multiple myeloma: literature review and our data. Part III

  S.S. Bessmeltsev

  137-174

  01.04.2014

• Organization of specialized medical care for patients with blood disorders in Saint Petersburg

  L.U. Zhiguleva, К.М. Abdulkadyrov

  1-8

  01.01.2014

• Rituximab (MabThera) for subcutaneous administration, new opportunities well-studied drug

  G.S. Tumyan

  67-70

  01.01.2014

• Genfatinib® therapy for chronic-phase chronic myeloid leukemia in routine clinical practice

  T.V. Chagorova, V.V. Yablokova, P.A. Borkina, N.A. Pryanikova

  434-438

  01.10.2013

• Hematopoietic stem cell transplantation in AML patients with t(8;21)(q22;q22) translocation

  N.N. Mamayev, A.V. Gorbunova, T.L. Gindina, I.M. Barkhatov, S.N. Bondarenko, M.Yu. Averyanova, О.V. Pirogova, O.V. Goloshchapov, Ye.V. Kondakova, B.V. Afanasyev

  439-444

  01.10.2013

• Mantle cell lymphoma: program therapy for untreated patients under 65 years

  V.I. Vorobyev, S.K. Kravchenko, E.G. Gemdjian, Yu.Yu. Lorie, A.U. Magomedova, A.L. Melikyan, J.K. Mangasarova, D.S. Mar’yin, E.I. Dubrovin, T.N. Obukhova, S.A. Makhinya, V.A. Zherebtsova, M.A. Vernyuk, N.G. Tyurina, V.G. Savchenko

  274-281

  01.07.2013

• International prognostic score in advanced Hodgkin’s lymphoma

  K.D. Kaplanov, A.L. Shipaeva, V.A. Vasil’yeva, E.G. Gemdjian, I.V. Matveeva, L.S. Tregubova, T.U. Klitochenko, K.V. Demidenko, O.B. Kalashnikova, G.U. Vyskub, O.E. Golubeva, O.V. Levina, V.A. Orlov, E.A. Demina

  294-302

  01.07.2013

• Cytogenetic remission as an important criterion for treatment efficacy in pediatric acute myeloid leukemia

  E.W. Fleischman, O.I. Sokova, A.V. Popa, V.S. Nemirovchenko, L.N. Konstantinova, N.F. Metelkova

  148-156

  01.04.2013

• Chronic hepatitis B and hematological malignancies

  A.O. Buyeverov, P.O. Bogomolov

  210-216

  01.04.2013

• Chimerism following allogeneic hematopoietic stem cell transplantation

  O.V. Blau

  34-39

  01.01.2013

• Management of refractory acute lymphoblastic leukemia in children and adolescents: remission re-induction followed by allogeneic hematopoietic stem cell transplantation

  E.V. Semenova, N.V. Stancheva, S.N. Bondarenko, V.N. Vavilov, D.A. Bagge, O.V. Paina, S.V. Razumova, A.S. Borovkova, T.A. Bykova, A.A. Raths, L.S. Zuborovskaya, B.V. Afanasyev

  53-59

  01.01.2013

• Cardiovascular complications of chronic myeloid leukemia treated with tyrosine kinase inhibitors

  G.E. Gendlin, L.M. Makeeva, E.I. Emelina, K.V. Shuikova, G.I. Storozhakov

  78-84

  01.01.2013

• Use of rituximab for treatment of HIV-infected patients with hematological disorders

  A.V. Pivnik

  85-91

  01.01.2013